Proteção à saúde no Brasil: o Sistema Nacional de Vigilância Sanitária

Seta, Marismary Horsth De; Oliveira, Cátia; Pepe, Vera Lúcia Edais

doi:10.1590/1413-812320172210.16672017

Cited by 14 publications

(10 citation statements)

References 13 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Health is inscribed in the national Constitution as a right for everyone and a duty of the Brazilian Republic. This was the framework for the creation of the Unified Health System, known as SUS, which contemplates the guidelines for health promotion and provision of services and establishes the community participation and transfer of federal resources to other jurisdictions [7,8]. Despite the great barriers that SUS has faced since its conception, it has managed to establish itself as a system that proposes to be an institutional redistributive model, guaranteeing universal coverage.…”

Section: The Sickle Cell Disease Network Of Care Inside Sus: From Neomentioning

confidence: 99%

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

Silva-Pinto

Queiroz

Zamaro

et al. 2019

IJNS

View full text Add to dashboard Cite

Since 2001, the Brazilian Ministry of Health has been coordinating a National Neonatal Screening Program (NNSP) that now covers all the 26 states and the Federal District of the Brazilian Republic and targets six diseases including sickle cell disease (SCD) and other hemoglobinopathies. In 2005, the program coverage reached 80% of the total live births. Since then, it has oscillated between 80% and 84% globally with disparities from one state to another (>95% in São Paulo State). The Ministry of Health has also published several Guidelines for clinical follow-up and treatment for the diseases comprised by the neonatal screening program. The main challenge was, and still is, to organize the public health network (SUS), from diagnosis and basic care to reference centers in order to provide comprehensive care for patients diagnosed by neonatal screening, especially for SCD patients. Considerable gains have already been achieved, including the implementation of a network within SUS and the addition of scientific and technological progress to treatment protocols. The goals for the care of SCD patients are the intensification of information provided to health care professionals and patients, measures to prevent complications, and care and health promotion, considering these patients in a global and integrated way, to reduce mortality and enhance their quality of life.

show abstract

Section: The Sickle Cell Disease Network Of Care Inside Sus: From Neomentioning

confidence: 99%

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

Silva-Pinto

Queiroz

Zamaro

et al. 2019

IJNS

View full text Add to dashboard Cite

show abstract

“…The median stroke cost per patient was US$7,470. Therefore, the Brazilian Health System stroke underfunding is a tremendous hurdle to overcome 19 . Thrombolysis and thrombectomy have been performed at the hospital since 2005 20 .…”

Section: Discussionmentioning

confidence: 99%

The cost of stroke in a public hospital in Brazil: a one-year prospective study

Safanelli

Vieira

Araujo

et al. 2019

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

Low- and middle-income countries face tight health care budgets, not only new resources, but also costly therapeutic resources for treatment of ischemic stroke (IS). However, few prospective data about stroke costs including cerebral reperfusion from low- and middle-income countries are available. Objective To measure the costs of stroke care in a public hospital in Joinville, Brazil. Methods We prospectively assessed all medical and nonmedical costs of inpatients admitted with a diagnosis of any stroke or transient ischemic attack over one year, analyzed costs per type of stroke and treatment, length of stay (LOS) and compared hospital costs with government reimbursement. Results We evaluated 274 patients. The total cost for the year was US$1,307,114; the government reimbursed the hospital US$1,095,118. We found a significant linear correlation between LOS and costs (r = 0.71). The median cost of 134 IS inpatients who did not undergo cerebral reperfusion (National Institutes of Health Stroke Scale [NIHSS] median = 3 ) was US$2,803; for IS patients who underwent intravenous (IV) alteplase (NIHSS 10), the median was US$5,099, and for IS patients who underwent IV plus an intra-arterial (IA) thrombectomy (NIHSS > 10), the median cost was US$10,997. The median costs of a primary intracerebral hemorrhage, subarachnoid hemorrhage, and transient ischemic attack were US$2,436, US$8,031 and US$2,677, respectively. Conclusions Reperfusion treatments were two-to-four times more expensive than conservative treatment. A cost-effectiveness study of the IS treatment option is necessary.

show abstract

“…Reivindicações de profissionais de saúde, grupos de pacientes de patologias específicas, Organizações Não-governamentais (ONGs) que defendem determinados procedimentos ou medicamentos, entidades de defesa do consumidor, conselhos de saúde, representantes de empresas e empresários, entidades sem fins lucrativos, pesquisadores, bem como integrantes do Poder Executivo das três esferas de governo, transitam em audiências públicas, em comissões especiais e em gabinetes de parlamentares. Assuntos que polarizaram as legislaturas pós-Constituição de 1988, entre outros, foram a legalização do aborto, a convenção-quadro do tabaco, a regulação da propaganda de alimentos e a proibição do uso de anorexígenos 32 .…”

Section: Interesses Alianças E Conflitos: O Sus E Os Poderes Da Repúunclassified

Trinta anos de Sistema Único de Saúde (SUS): uma transição necessária, mas insuficiente

Bahia

2018

Cad. Saúde Pública

View full text Add to dashboard Cite

This article describes changes in the public, nonprofit, and private components of the health care networks and health insurance and health plan companies in Brazil, based on the accumulated knowledge concerning the gains and obstacles in the Brazilian Unified National Health System (SUS) and differences between policies for democratization and democratizing processes. This central premise allowed analyzing praise versus criticism for the SUS and the contemporary nature of relations between the public and private sectors, drawing on secondary data from agencies in the Executive, Legislative, and Judiciary branches. The article concludes that the highly financialized private and private-charitable sectors imposed anti-democratic and anti-democratizing standards in the use of public funds. The article further concludes that although these sectors have not raised barriers to certain public policies for the expansion of access, they nevertheless prevent the development of the SUS according to the principles set out in the 1988 Constitution.

show abstract

Proteção à saúde no Brasil: o Sistema Nacional de Vigilância Sanitária

Abstract: This essay presents the singular arrangement named Health Surveillance in Brazil and

Cited by 14 publications

References 13 publications

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

The cost of stroke in a public hospital in Brazil: a one-year prospective study

Trinta anos de Sistema Único de Saúde (SUS): uma transição necessária, mas insuficiente

Contact Info

Product

Resources

About